Abstract:To study the inhibitory effect, mechanism, and safety of ginsenosides Rg5 towards cancer cells, CCK-8 assay was conducted to screen the sensitive cancer cell line. Then the mechanisms and safety of Rg5 were studied via various of assays. The flow cytometry was applied to evaluate the apoptosis and cell cycle of sensitive cancer cells treated with Rg5. The cancer cell migration and invasion were studied via scratching experiment and transwell assay. Besides, the disturbance of protein expression in sensitive cells treated with Rg5 was measured by Western Blot experiment. The binding modes between Rg5 and MMP-2 or MMP-9 were simulated by Auto Dock study. Furthermore, the safety of Rg5 was evaluated via animal experiments. The results indicated that Hela cells were sensitive towards Rg5 among the Hela, MCF-7, HCT116, HepG2, A549, SiHa, and CaSki cells. The 72 h-IC50 value was 53.02 μmol·L-1. The Rg5 could induce Hela cell apoptosis, arrest Hela cells at G2/M phase, and inhibit migration and invasion of Hela cells. The results of Western Blot assay demonstrated that Rg5 could activate the mitochondrial apoptosis pathway, reduce the expression of MMP-2, MMP-9, E-cadherin, and cancer cell stemness factors. Auto Dock study indicated that Rg5 could bind into the hydrophobic pockets of MMP-2 and MMP-9. The in vivo safety experiments showed that Rg5 exhibited no obvious disturbance or damage towards the function of liver and kidney, the indexes of blood routine, and the major organs of mice. As a natural produc, Rg5 could induce apoptosis via initiating the apoptosis pathway and suppress cell invasion via down-regulating the expression of cancer stemness related factors, MMP-2, and MMP-9. The results provided theoretical support for the further development and utilization of Rg5 in the field of functional food and health products.